Javier A. Bravo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Javier A. Bravo has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Marcela Julio-Pieper
Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Chile
5 shared publications - Ramón Sotomayor-Zárate
Centro de Neurobiología y Fisiopatología Integrativa (CENFI), Facultad de Ciencias, Universidad de Valparaíso, Chile
5 shared publications Marcela Julio-Pieper
Laboratorio de Neuroquímica y Neurofarmacología, Centro de Neurobiología y Fisiopatología Integrativa (CENFI), Instituto de Fisiología, Facultad de Ciencias, Universidad de Valparaíso, Valparaíso, Chile
3 shared publications- Alejandra López-Aguilera
Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso 2340000, Chile
2 shared publications Camila González-Arancibia
Laboratorio de Neuroquímica y Neurofarmacología, Centro de Neurobiología y Fisiopatología Integrativa (CENFI), Instituto de Fisiología, Facultad de Ciencias, Universidad de Valparaíso, Valparaíso, Chile
2 shared publications- Jonathan Martínez-Pinto
Instituto de Fisiología, Facultad de Ciencias, Universidad de Valparaíso, Valparaíso, Chile
2 shared publications
Latest Publications
- Open Access
- 27 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (12) , 1807
Distinct Swimming Behavioral Phenotypes Following Serotonin and Dopamine Transporter Modulation in the Adult Zebrafish Novel Tank Diving Test (NTT)
Background/Objective: Serotonin and dopamine are key neurotransmitters involved in regulating mood, anxiety, and locomotor activity. Specific transporters mediate their reuptake, SERT and DAT, making them targets for drugs such as Fluoxetine and Methylphenidate. Zebrafish (Danio rerio), due to their genetic and neurochemical similarity to humans, serve as a valuable model for studying the behavioral effects of these drugs. This study aimed to compare the behavioral phenotypes induced by SERT and DAT blockers in adult zebrafish using the Novel Tank Diving Test (NTT), thereby generating a swimming profile for drugs acting on these monoamine transporters that can be utilized in drug discovery and behavior. Methods: Adult zebrafish were administered Fluoxetine or Methylphenidate and subjected to the NTT. Behavioral endpoints measured included bottom-dwelling time (anxiety-like behavior), swimming velocity (locomotor activity), and transitions to the upper zone (exploratory behavior). Results: Fluoxetine treatment significantly reduced bottom-dwelling behavior, increased transitions to the upper zone, and decreased erratic swimming, indicating reduced anxiety and enhanced exploration. In contrast, Methylphenidate administration led to prolonged bottom-dwelling and reduced exploration, suggesting increased anxiety-like behavior and decreased exploration. These findings highlight distinct behavioral profiles resulting from selective modulation of serotonergic and dopaminergic pathways. Conclusions: The study demonstrates that SERT and DAT blockades produce divergent behavioral effects in adult zebrafish, with Fluoxetine exhibiting anxiolytic and exploratory-promoting actions. At the same time, Methylphenidate induces anxiety-like and less exploratory behaviors. These results underscore the utility of zebrafish as a valuable translational model for neuropharmacological research and drug discovery, providing insights into the differential impact of serotonergic and dopaminergic modulation on behavior.
- 27 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (12) , 1807
Open AccessDistinct Swimming Behavioral Phenotypes Following Serotonin and Dopamine Transporter Modulation in the Adult Zebrafish Novel Tank Diving Test (NTT)
Background/Objective: Serotonin and dopamine are key neurotransmitters involved in regulating mood, anxiety, and locomotor activity. Specific transporters mediate their reuptake, SERT and DAT, making them targets for drugs such as Fluoxetine and Methylphenidate. Zebrafish (Danio rerio), due to their genetic and neurochemical similarity to humans, serve as a valuable model for studying the behavioral effects of these drugs. This study aimed to compare the behavioral phenotypes induced by SERT and DAT blockers in adult zebrafish using the Novel Tank Diving Test (NTT), thereby generating a swimming profile for drugs acting on these monoamine transporters that can be utilized in drug discovery and behavior. Methods: Adult zebrafish were administered Fluoxetine or Methylphenidate and subjected to the NTT. Behavioral endpoints measured included bottom-dwelling time (anxiety-like behavior), swimming velocity (locomotor activity), and transitions to the upper zone (exploratory behavior). Results: Fluoxetine treatment significantly reduced bottom-dwelling behavior, increased transitions to the upper zone, and decreased erratic swimming, indicating reduced anxiety and enhanced exploration. In contrast, Methylphenidate administration led to prolonged bottom-dwelling and reduced exploration, suggesting increased anxiety-like behavior and decreased exploration. These findings highlight distinct behavioral profiles resulting from selective modulation of serotonergic and dopaminergic pathways. Conclusions: The study demonstrates that SERT and DAT blockades produce divergent behavioral effects in adult zebrafish, with Fluoxetine exhibiting anxiolytic and exploratory-promoting actions. At the same time, Methylphenidate induces anxiety-like and less exploratory behaviors. These results underscore the utility of zebrafish as a valuable translational model for neuropharmacological research and drug discovery, providing insights into the differential impact of serotonergic and dopaminergic modulation on behavior.
- 24 November 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (11) , e70301
Lateral Septum as a Key Integrative Regulator of Feeding: Role of the GLP ‐1/ GLP ‐ 1R System
The control of food intake represents a multifaceted process involving a dynamic interaction between various cerebral regions and peripheral signals. This control incorporates both homeostatic and hedonic systems, contingent upon whether it is responding to nutritional status or to the reward mechanisms associated with food consumption. The lateral septum (LS) functions as a pivotal neural relay center, exerting an effect on alimentary intake upon activation. Due to its extensive neural connections with other cerebral nuclei, the LS is integrated with circuits governing both homeostatic and hedonic feeding controls. Recent investigations have elucidated a connection between the glucagon‐like peptide 1 (GLP‐1) system and the LS, revealing that the activation of the GLP‐1 receptor (GLP‐1R) within this region modulates food intake. We present several recent findings highlighting the critical role of the LS in food intake control, alongside the importance of the GLP‐1 system within this neural context. Additionally, we advocate for further research on the GLP‐1/GLP‐1R system in the LS as a therapeutic target for obesity. image
- 24 November 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (11) , e70301
Lateral Septum as a Key Integrative Regulator of Feeding: Role of the GLP ‐1/ GLP ‐ 1R System
The control of food intake represents a multifaceted process involving a dynamic interaction between various cerebral regions and peripheral signals. This control incorporates both homeostatic and hedonic systems, contingent upon whether it is responding to nutritional status or to the reward mechanisms associated with food consumption. The lateral septum (LS) functions as a pivotal neural relay center, exerting an effect on alimentary intake upon activation. Due to its extensive neural connections with other cerebral nuclei, the LS is integrated with circuits governing both homeostatic and hedonic feeding controls. Recent investigations have elucidated a connection between the glucagon‐like peptide 1 (GLP‐1) system and the LS, revealing that the activation of the GLP‐1 receptor (GLP‐1R) within this region modulates food intake. We present several recent findings highlighting the critical role of the LS in food intake control, alongside the importance of the GLP‐1 system within this neural context. Additionally, we advocate for further research on the GLP‐1/GLP‐1R system in the LS as a therapeutic target for obesity. image
- 4 September 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (9) , e70224
Juvenile Rats Exposed to Antibiotics Early in Life Display Sexual Dimorphisms on Social Behaviour and Sex Hormone Deconjugating Activity
Investigations addressing addiction and social behaviour have found differences between males and females (men and women). Early life exposure to antibiotics (ELEA) induces addiction − like behaviours in adult male Sprague–Dawley (SD) rats, but not in females, while changing dopamine neurochemistry in females but not in males (doi: 10.3389/fphar.2022.837652 ). Female oestrogen regulates brain dopamine levels and release, while oestrogen circulation is influenced by gut microbes through intestinal β‐glucuronidase activity, which further contributes to oestrogen's impact on the brain. Since the dopaminergic system is an important regulator of social behaviour and its function is affected by oestradiol concentrations, we asked whether ELEA impacts these behaviours later in life and if changes in intestinal gut β‐glucuronidase activity relate to these changes. ELEA was achieved by oral administration of bacitracin, neomycin, vancomycin (100 mg/kg each) and pimaricin (5 μg/kg) to pregnant SD dams from embryonic Day 18 to postnatal day (PND) 7. Vehicle‐treated pregnant SD dams served as controls. Behavioural analysis was conducted on male and female offspring from PND 35–37. Half of the subjects underwent gonadectomy (GDX) to remove the influence of sex steroids. ELEA prevented weight loss associated with behavioural testing in males. Three‐way ANOVA revealed a main effect of ELEA, reducing pinning, pouncing, total time of social play and social grooming. In GDX males, ELEA diminished social interaction in the presence of an unknown rat. β‐glucuronidasee activity was reduced in females by ELEA and GDX. ELEA reduces some social behaviours in a sex‐independent manner, while sex‐dependently lowering intestinal beta‐glucuronidase activity, suggesting that early‐life gut symbiont acquisition influences social coping strategies and intestinal oestradiol metabolism later in life. image
- 4 September 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (9) , e70224
Juvenile Rats Exposed to Antibiotics Early in Life Display Sexual Dimorphisms on Social Behaviour and Sex Hormone Deconjugating Activity
Investigations addressing addiction and social behaviour have found differences between males and females (men and women). Early life exposure to antibiotics (ELEA) induces addiction − like behaviours in adult male Sprague–Dawley (SD) rats, but not in females, while changing dopamine neurochemistry in females but not in males (doi: 10.3389/fphar.2022.837652 ). Female oestrogen regulates brain dopamine levels and release, while oestrogen circulation is influenced by gut microbes through intestinal β‐glucuronidase activity, which further contributes to oestrogen's impact on the brain. Since the dopaminergic system is an important regulator of social behaviour and its function is affected by oestradiol concentrations, we asked whether ELEA impacts these behaviours later in life and if changes in intestinal gut β‐glucuronidase activity relate to these changes. ELEA was achieved by oral administration of bacitracin, neomycin, vancomycin (100 mg/kg each) and pimaricin (5 μg/kg) to pregnant SD dams from embryonic Day 18 to postnatal day (PND) 7. Vehicle‐treated pregnant SD dams served as controls. Behavioural analysis was conducted on male and female offspring from PND 35–37. Half of the subjects underwent gonadectomy (GDX) to remove the influence of sex steroids. ELEA prevented weight loss associated with behavioural testing in males. Three‐way ANOVA revealed a main effect of ELEA, reducing pinning, pouncing, total time of social play and social grooming. In GDX males, ELEA diminished social interaction in the presence of an unknown rat. β‐glucuronidasee activity was reduced in females by ELEA and GDX. ELEA reduces some social behaviours in a sex‐independent manner, while sex‐dependently lowering intestinal beta‐glucuronidase activity, suggesting that early‐life gut symbiont acquisition influences social coping strategies and intestinal oestradiol metabolism later in life. image
- Open Access
- 30 June 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 837652
Early-Life Exposure to Non-Absorbable Broad-Spectrum Antibiotics Affects the Dopamine Mesocorticolimbic Pathway of Adult Rats in a Sex-Dependent Manner
Gut microbiota with a stable, rich, and diverse composition is associated with adequate postnatal brain development. Colonization of the infant’s gut begins at birth when parturition exposes the newborn to a set of maternal bacteria, increasing richness and diversity until one to two first years of age when a microbiota composition is stable until old age. Conversely, alterations in gut microbiota by diet, stress, infection, and antibiotic exposure have been associated with several pathologies, including metabolic and neuropsychiatric diseases such as obesity, anxiety, depression, and drug addiction, among others. However, the consequences of early-life exposure to antibiotics (ELEA) on the dopamine (DA) mesocorticolimbic circuit are poorly studied. In this context, we administered oral non-absorbable broad-spectrum antibiotics to pregnant Sprague-Dawley dams during the perinatal period (from embryonic day 18 until postnatal day 7) and investigated their adult offspring (postnatal day 60) to assess methylphenidate-induced conditioned place preference (CPP) and locomotor activity, DA release, DA and 3,4-dihydroxyphenylacetic acid (DOPAC) content in ventral tegmental area (VTA), and expression of key proteins within the mesocorticolimbic system. Our results show that ELEA affect the rats conduct by increasing drug-seeking behavior and locomotor activity induced by methylphenidate of males and females, respectively, while reducing dopamine striatal release and VTA content of DOPAC in females. In addition, antibiotics increased protein levels of DA type 1 receptor in prefrontal cortex and VTA of female rats, and tyrosine hydroxylase in VTA of adult male and female rats. Altogether, these results suggest that ELEA alters the development of the microbiota-gut-brain axis affecting the reward system and the response to abuse drugs in adulthood.
- 30 June 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 837652
Open AccessEarly-Life Exposure to Non-Absorbable Broad-Spectrum Antibiotics Affects the Dopamine Mesocorticolimbic Pathway of Adult Rats in a Sex-Dependent Manner
Gut microbiota with a stable, rich, and diverse composition is associated with adequate postnatal brain development. Colonization of the infant’s gut begins at birth when parturition exposes the newborn to a set of maternal bacteria, increasing richness and diversity until one to two first years of age when a microbiota composition is stable until old age. Conversely, alterations in gut microbiota by diet, stress, infection, and antibiotic exposure have been associated with several pathologies, including metabolic and neuropsychiatric diseases such as obesity, anxiety, depression, and drug addiction, among others. However, the consequences of early-life exposure to antibiotics (ELEA) on the dopamine (DA) mesocorticolimbic circuit are poorly studied. In this context, we administered oral non-absorbable broad-spectrum antibiotics to pregnant Sprague-Dawley dams during the perinatal period (from embryonic day 18 until postnatal day 7) and investigated their adult offspring (postnatal day 60) to assess methylphenidate-induced conditioned place preference (CPP) and locomotor activity, DA release, DA and 3,4-dihydroxyphenylacetic acid (DOPAC) content in ventral tegmental area (VTA), and expression of key proteins within the mesocorticolimbic system. Our results show that ELEA affect the rats conduct by increasing drug-seeking behavior and locomotor activity induced by methylphenidate of males and females, respectively, while reducing dopamine striatal release and VTA content of DOPAC in females. In addition, antibiotics increased protein levels of DA type 1 receptor in prefrontal cortex and VTA of female rats, and tyrosine hydroxylase in VTA of adult male and female rats. Altogether, these results suggest that ELEA alters the development of the microbiota-gut-brain axis affecting the reward system and the response to abuse drugs in adulthood.
- Open Access
- 29 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (9) , 4734
Gut Susceptibility to Viral Invasion: Contributing Roles of Diet, Microbiota and Enteric Nervous System to Mucosal Barrier Preservation
The gastrointestinal lumen is a rich source of eukaryotic and prokaryotic viruses which, together with bacteria, fungi and other microorganisms comprise the gut microbiota. Pathogenic viruses inhabiting this niche have the potential to induce local as well as systemic complications; among them, the viral ability to disrupt the mucosal barrier is one mechanism associated with the promotion of diarrhea and tissue invasion. This review gathers recent evidence showing the contributing effects of diet, gut microbiota and the enteric nervous system to either support or impair the mucosal barrier in the context of viral attack.
- 29 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (9) , 4734
Open AccessGut Susceptibility to Viral Invasion: Contributing Roles of Diet, Microbiota and Enteric Nervous System to Mucosal Barrier Preservation
The gastrointestinal lumen is a rich source of eukaryotic and prokaryotic viruses which, together with bacteria, fungi and other microorganisms comprise the gut microbiota. Pathogenic viruses inhabiting this niche have the potential to induce local as well as systemic complications; among them, the viral ability to disrupt the mucosal barrier is one mechanism associated with the promotion of diarrhea and tissue invasion. This review gathers recent evidence showing the contributing effects of diet, gut microbiota and the enteric nervous system to either support or impair the mucosal barrier in the context of viral attack.
- 17 May 2019
- Published by Springer Nature in Psychopharmacology
- Vol. 236 (5) , 1611-1622
Do your gut microbes affect your brain dopamine?
Increasing evidence shows changes in gut microbiota composition in association with psychiatric disorders, including anxiety and depression. Moreover, it has been reported that perturbations in gut microbe diversity and richness influence serotonergic, GABAergic, noradrenergic, and dopaminergic neurotransmission. Among these, dopamine is regarded as a main regulator of cognitive functions such as decision making, attention, memory, motivation, and reward. In this work, we will highlight findings that link alterations in intestinal microbiota and dopaminergic neurotransmission, with a particular emphasis on the mesocorticolimbic circuit, which is involved in reward to natural reinforcers, as well as abuse substances. For this, we reviewed evidence from studies carried out on germ-free animals, or in rodents subjected to intestinal dysbiosis using antibiotics, and also through the use of probiotics. All this evidence strongly supports that the microbiota-gut-brain axis is key to the physiopathology of several neuropsychiatric disorders involving those where dopaminergic neurotransmission is compromised. In addition, the gut microbiota appears as a key player when it comes to proposing novel strategies to the treatment of these psychiatric conditions.
- 17 May 2019
- Published by Springer Nature in Psychopharmacology
- Vol. 236 (5) , 1611-1622
Do your gut microbes affect your brain dopamine?
Increasing evidence shows changes in gut microbiota composition in association with psychiatric disorders, including anxiety and depression. Moreover, it has been reported that perturbations in gut microbe diversity and richness influence serotonergic, GABAergic, noradrenergic, and dopaminergic neurotransmission. Among these, dopamine is regarded as a main regulator of cognitive functions such as decision making, attention, memory, motivation, and reward. In this work, we will highlight findings that link alterations in intestinal microbiota and dopaminergic neurotransmission, with a particular emphasis on the mesocorticolimbic circuit, which is involved in reward to natural reinforcers, as well as abuse substances. For this, we reviewed evidence from studies carried out on germ-free animals, or in rodents subjected to intestinal dysbiosis using antibiotics, and also through the use of probiotics. All this evidence strongly supports that the microbiota-gut-brain axis is key to the physiopathology of several neuropsychiatric disorders involving those where dopaminergic neurotransmission is compromised. In addition, the gut microbiota appears as a key player when it comes to proposing novel strategies to the treatment of these psychiatric conditions.
- 3 November 2018
- Published by Springer Nature in Current Behavioral Neuroscience Reports
- Vol. 5 (4) , 211-217
Do Obese Bacteria Make us “Want them”? Intestinal Microbiota, Mesocorticolimbic Circuit and Non-Homeostatic Feeding
- 3 November 2018
- Published by Springer Nature in Current Behavioral Neuroscience Reports
- Vol. 5 (4) , 211-217
Do Obese Bacteria Make us “Want them”? Intestinal Microbiota, Mesocorticolimbic Circuit and Non-Homeostatic Feeding
- 1 September 2017
- Published by Elsevier in Neuroscience
- Vol. 359, 18-29
Anxiogenic effects of a Lactobacillus, inulin and the synbiotic on healthy juvenile rats
- 1 September 2017
- Published by Elsevier in Neuroscience
- Vol. 359, 18-29
Anxiogenic effects of a Lactobacillus, inulin and the synbiotic on healthy juvenile rats